Suppr超能文献

2021 年马拉维接受抗逆转录病毒治疗的儿童和成人中与艾滋病毒病毒抑制相关的因素:来自实验室管理信息系统的证据。

Factors associated with HIV viral suppression among children and adults receiving antiretroviral therapy in Malawi in 2021: Evidence from the Laboratory Management Information System.

机构信息

Institute of Global Health, University of Geneva, Geneva, Switzerland.

Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences, Lilongwe, Malawi.

出版信息

Trop Med Int Health. 2022 Jul;27(7):639-646. doi: 10.1111/tmi.13782. Epub 2022 Jun 14.

Abstract

OBJECTIVE

To describe the prevalence of HIV viral suppression and assess the factors associated with HIV viral suppression among persons receiving antiretroviral therapy (ART) in Malawi in 2021.

METHODS

Implementation study using routinely collected patient-level HIV RNA-PCR test result data extracted from the national Laboratory Management Information System (LIMS) database managed by the Department of HIV/AIDS in 2021. We calculated frequencies, proportions and odds ratios (OR) of HIV viral suppression with their associated 95% confidence intervals (95%CIs). We performed a random-effects logistic regression to determine the risk factors associated with HIV viral suppression among ART patients, controlling for the spatial autocorrelation between districts and adjusting for other variables.

RESULTS

We evaluated 515,797 adults and children receiving ART and having a viral load test in 2021. Of these, 92.8% had HIV viral suppression. ART patients living in urban areas had lower likelihood of HIV viral suppression than those living in rural areas (adjusted OR [aOR] = 0.95, 95%CI: 0.92-0.99, p = 0.01). There was an increasing trend in HIV viral suppression with increasing ART duration. Routine VL monitoring samples were 39% more likely to have suppressed VL values than confirmatory HIV VL monitoring samples (aOR = 1.39; 95%CI: 1.34-1.43, p < 0.001).

CONCLUSION

This is the first national analysis of Malawi HIV VL data from LIMS. Our findings show the need to particularly consider the urban residents, those below 20 years, males, those on ART for less than a year as well as those on specific ARV regimens in order to persistently suppress HIV VL and consequently achieve the goal of achieving HIV VL suppression by 2030.

摘要

目的

描述 2021 年马拉维接受抗逆转录病毒疗法(ART)的患者中 HIV 病毒抑制的流行情况,并评估与 HIV 病毒抑制相关的因素。

方法

这是一项使用 2021 年从国家艾滋病毒/艾滋病部管理的实验室管理信息系统(LIMS)数据库中提取的常规收集的患者级 HIV RNA-PCR 检测结果数据进行的实施研究。我们计算了 HIV 病毒抑制的频率、比例和比值比(OR)及其 95%置信区间(95%CI)。我们进行了随机效应逻辑回归,以确定 ART 患者中与 HIV 病毒抑制相关的风险因素,同时控制了地区之间的空间自相关,并调整了其他变量。

结果

我们评估了 2021 年接受 ART 治疗且有病毒载量检测的 515797 名成人和儿童。其中,92.8%的患者 HIV 病毒得到了抑制。与居住在农村地区的患者相比,居住在城市地区的 ART 患者 HIV 病毒抑制的可能性较低(调整后的比值比[aOR] = 0.95,95%CI:0.92-0.99,p = 0.01)。随着 ART 持续时间的增加,HIV 病毒抑制呈上升趋势。常规 VL 监测样本比确认性 HIV VL 监测样本更有可能具有抑制的 VL 值(aOR = 1.39;95%CI:1.34-1.43,p < 0.001)。

结论

这是首次对来自 LIMS 的马拉维 HIV VL 数据进行的全国性分析。我们的研究结果表明,需要特别关注城市居民、20 岁以下的人、男性、接受 ART 不到一年的人以及特定抗逆转录病毒方案的人,以持续抑制 HIV VL,并最终实现到 2030 年实现 HIV VL 抑制的目标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验